Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Thematic (Sector/Industry)

<ul><li>The US cannabis MSOS ETF fell for the fourth time in the last five weeks.</li><li>MSOS finished -8.68%, while the global YOLO ETF finished -7.99%. YTD, MSOS is +19.64% and YOLO is +10.59%.</li><li>MSOS hit a 52-week high on February 6 at $10.64 and has since fallen 23.87%. Interestingly, since February 6, the fund has received $77.13 million in inflows.</li></ul>

The US cannabis MSOS ETF fell for the fourth time in the last five weeks.MSOS finished -8.68%, while the global YOLO ETF finished -7.99%. YTD, MSOS is +19.64% and YOLO is +10.59%.MSOS hit a 52-week high on February 6 at $10.64 and has since fallen 23.87%. Interestingly, since February 6, the fund has received $77.13 million in inflows.

The Highlights - Cannabis News for the Week Ending March 8, 2024

Equity Bottom-Up

<ul><li>MariMed reported 4Q revenue of $38.9 million, which was exactly in line with our estimate.</li><li>This represents a 0.26% increase Q/Q and an 8.66% improvement Y/Y. Gross margins were 44.47%, a gain of 1.80% sequentially and 0.34% Y/Y.</li><li>Revenue was helped by a full contribution from the Thrive Dispensary in Casey, Illinois and beginning operations at the Mt. Vernon, Illinois manufacturing facility. </li></ul>

MariMed reported 4Q revenue of $38.9 million, which was exactly in line with our estimate.This represents a 0.26% increase Q/Q and an 8.66% improvement Y/Y. Gross margins were 44.47%, a gain of 1.80% sequentially and 0.34% Y/Y.Revenue was helped by a full contribution from the Thrive Dispensary in Casey, Illinois and beginning operations at the Mt. Vernon, Illinois manufacturing facility. 

MariMed, Inc. - Poised for Growth in 2024

<ul><li>The US cannabis MSOS ETF fell 7.80% last week, its third loss in the last four weeks.</li><li>Earnings this week were relatively strong, but sentiment around federal reform may be driving short-term prices.</li><li>Despite the sell- off, MSOS had $1.8 million in inflows. The global YOLO ETF held up better, losing 1.89% over the last five sessions.</li></ul>

The US cannabis MSOS ETF fell 7.80% last week, its third loss in the last four weeks.Earnings this week were relatively strong, but sentiment around federal reform may be driving short-term prices.Despite the sell- off, MSOS had $1.8 million in inflows. The global YOLO ETF held up better, losing 1.89% over the last five sessions.

The Highlights - Cannabis News for the Week Ending March 1, 2024

<ul><li>The US cannabis MSOS ETF broke a two-week slide and gained 6.77% over the holiday-shortened four- day trading week.</li><li>Once again, the global YOLO ETF lagged at just 0.27% over the same stretch. MSOS is +37.23% YTD, while YOLO is +22.18%.</li><li>The discrepancy shows the increased interest in US cannabis due to the potential for rescheduling and the continuing difficult environment for most Canadian operators.</li></ul>

The US cannabis MSOS ETF broke a two-week slide and gained 6.77% over the holiday-shortened four- day trading week.Once again, the global YOLO ETF lagged at just 0.27% over the same stretch. MSOS is +37.23% YTD, while YOLO is +22.18%.The discrepancy shows the increased interest in US cannabis due to the potential for rescheduling and the continuing difficult environment for most Canadian operators.

The Highlights - Cannabis News for the Week Ending February 23, 2024

<ul><li>Cannabis stocks sold off for the second straight week. The US cannabis MSOS ETF lost 6.44%, while the global YOLO ETF fell 15.19%.</li><li>In the absence of meaningful news, we saw profit taking while we wait for earnings and news from the DEA.</li><li>This week, MSOS had $15,088,000 in inflows. So far in February, total inflows have been $91,345,550, which is $8,304,140 on average per trading session.</li></ul>

Cannabis stocks sold off for the second straight week. The US cannabis MSOS ETF lost 6.44%, while the global YOLO ETF fell 15.19%.In the absence of meaningful news, we saw profit taking while we wait for earnings and news from the DEA.This week, MSOS had $15,088,000 in inflows. So far in February, total inflows have been $91,345,550, which is $8,304,140 on average per trading session.

The Highlights - Cannabis News for the Week Ending February 16, 2024

United States

MariMed, Inc. operates as a pharmaceutical company. The Company specializes in designing, development, operation, funding, and optimization of medical cannabis cultivation, production centers, and dispensaries. MariMed serves customers in the State of Massachusetts.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MariMed (MRMD US)

The Highlights - Cannabis News for the Week Ending March 8, 2024

The US cannabis MSOS ETF fell for the fourth time in the last five weeks. MSOS finished -8.68%, while the global YOLO ETF finished -7.99%. YTD,...

Water Tower Research

MariMed, Inc. - Poised for Growth in 2024

Revenue was helped by a full contribution from the Thrive Dispensary in Casey, Illinois and beginning operations at the Mt. Vernon, Illinois...

Water Tower Research

The Highlights - Cannabis News for the Week Ending March 1, 2024

Despite the sell- off, MSOS had $1.8 million in inflows. The global YOLO ETF held up better, losing 1.89% over the last five sessions.

Water Tower Research

The Highlights - Cannabis News for the Week Ending February 23, 2024

The discrepancy shows the increased interest in US cannabis due to the potential for rescheduling and the continuing difficult environment for most...

Water Tower Research

The Highlights - Cannabis News for the Week Ending February 16, 2024

Cannabis stocks sold off for the second straight week. The US cannabis MSOS ETF lost 6.44%, while the global YOLO ETF fell 15.19%.

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)